
The U.S. Centers for Disease Control and Prevention (CDC) last week backed an additional dose of the Pfizer Inc /BioNTech vaccine for Americans aged 65 and older, adults with underlying medical conditions and adults in high-risk working and institutional settings.
from International-News-Economic Times https://ift.tt/3EUyZqv
via
IFTTT
0 comments:
Post a Comment